As of 2024-07-27, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 99.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -45.7%.
The range of the Relative Valuation is 81.87 - 134.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 43.9x | 36.6x |
| Forward P/E multiples | 31.5x - 37.1x | 33.0x |
| Fair Price | 81.87 - 134.90 | 99.12 |
| Upside | -55.1% - -26.1% | -45.7% |
| Date | P/E |